http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102850282-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-24 |
| filingDate | 2012-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102850282-B |
| titleOfInvention | 3-substituted oxy-2-Zinamide compounds and uses thereof |
| abstract | The present invention relates to a kind of 3-alkoxyl group with general formula I and replace-2-Zinamide compounds and the application in preparation antiviral thereof; Compound involved in the present invention is that T1105 or T705 plays antivirus action by esterase or P450 enzymes metabolism in vivo.Compared with proto-drug T1105 or T705, it is high that compound of Formula I involved in the present invention has bioavailability, the obviously advantage such as long action time in body. |
| priorityDate | 2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.